manilatimes10h
Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform Technology
Sonnet's F H AB platform consists of a single, fully human construct of a F H AB antibody fragment that has high affinity to ...
Armed robbery in Revesby5d
Bioinspired Surface Engineering Speeds AMP Detection
Researchers from Jiangsu University have developed a cutting-edge molecularly imprinted polymer (MIP) system that could revolutionize the specific ...
technologynetworks6d
Advancing Antibody Innovation Through Discovery, Customization and Sustainability
In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...
Boster Biological Technology Revolutionizes Biotechnology Research with Advanced Multiplex ELISA Service
Pleasanton, California - Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA ...
bioAffinity secures Australian patent for lung cancer test
SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage lung ...
BioAffinity patent application accepted by IP Australia for early stage LC test
Affinity Technologie announced that the Australian Patent Office or IP Australia, has accepted bioAffinity’s patent application for the ...
Joplin Globe6d
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic ...
Patrick Cantlay doesn't listen to music made after this year, throw TGL hammer when up
Cantlay, who still doesn't listen to any music made after 1980, advised his TGL team, Atlanta Drive, to hold onto the hammer ...